Serum IL-31 levels are increased in a subset of patients with mastocytosis and correlate with disease severity in adult patients

Journal of Allergy and Clinical Immunology

Volumn 132, Issue 1, 2013, Pages

  Hartmann, Karin ^a   Wagner, Nicola ^b   Rabenhorst, Anja ^a   Pflanz, Liselotte ^a   Leja, Silke ^a   Förster, Anja ^a   Gehring, Manuela ^c   Kapp, Alexander ^c   Raap, Ulrike ^c  

^a UNIVERSITY OF COLOGNE   (Germany)

^b KLINIKUM DARMSTADT   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CLADRIBINE; CYTOKINE; INTERLEUKIN 31; NEUROPEPTIDE; PROTEIN TYROSINE KINASE INHIBITOR; TRYPTASE;

ADULT; ATOPIC DERMATITIS; BLOOD LEVEL; BONE MARROW; DISEASE SEVERITY; GENE MUTATION; HUMAN; LETTER; MAJOR CLINICAL STUDY; MASTOCYTOSIS; PRIORITY JOURNAL; ULTRAVIOLET IRRADIATION;

EID: 84882879102     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2012.11.008     Document Type: Article

References (9)

1. Horny HP, Metcalfe DD, Bennett JM, Bain BJ, Akin C, Escribano L, et al. Mastocytosis. In: Jaffe ES, Harris NL, Stein H, JW V, editors. World Health Organization classification of tumours pathology and genetics of tumours of the haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008. p. 54-63.
2. Sanchez-Munoz L, Alvarez-Twose I, Garcia-Montero AC, Teodosio C, Jara-Ace-vedo M, Pedreira CE, et al. Evaluation of the WHO criteria for the classification of patients with mastocytosis. Mod Pathol 2011;24:1157-68.
3. Escribano L, Alvarez-Twose I, Sanchez-Munoz L, Garcia-Montero A, Nunez R, Almeida J, et al. Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients. J Allergy Clin Immunol 2009;124:514-21.
4. Akin C, Metcalfe DD. Surrogate markers of disease in mastocytosis. Int Arch Allergy Immunol 2002;127:133-6.
5. Dillon SR, Sprecher C, Hammond A, Bilsborough J, Rosenfeld-Franklin M, Presnell SR, et al. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol 2004;5:752-60.
6. Cornelissen C, Lüscher-Firzlaff J, Baron JM, Lüscher B. Signaling by IL-31 and functional consequences. Eur J Cell Biol 2012;91:552-66.
7. Raap U, Wichmann K, Bruder M, Ständer S, Wedi B, Kapp A, et al. Correlation of IL-31 serum levels with severity of atopic dermatitis. JAllergy Clin Immunol 2008;122:421-3.
8. Niyonsaba F, Ushio H, Hara M, Yokoi H, Tominaga M, Takamori K, et al. Antimicrobial peptides human b-defensins and cathelicidin LL-37 induce the secretion of a pruritogenic cytokine IL-31 by human mast cells. J Immunol 2010;184:3526-34.
9. Kushnir-Sukhov NM, Brittain E, Reynolds JC, Akin C, Metcalfe DD. Elevated tryptase levels are associated with greater bone density in a cohort of patients with mastocytosis. Int Arch Allergy Immunol 2006;139:265-70.